Journal of Medicinal Chemistry

About the Journal

The Journal of Medicinal Chemistry is a premier open-access, peer-reviewed platform dedicated to the design, synthesis, and development of bioactive molecules with therapeutic potential. As the interface between chemistry and biology continues to drive drug discovery, this journal serves as a vital resource for scientists exploring the molecular basis of disease and innovation in pharmaceutical agents.

Focused on the intersection of chemistry, pharmacology, and molecular biology, the journal publishes cutting-edge research that advances the understanding of structure-activity relationships, novel synthetic pathways, and the optimization of lead compounds. Our scope spans a wide range of topics including molecular modeling, chemical biology, target identification, prodrug strategies, and the discovery of small molecules, peptides, and biologics.

We welcome high-impact contributions across therapeutic areas such as oncology, infectious diseases, neurological disorders, inflammation, metabolic conditions, and rare diseases. Studies exploring new chemical scaffolds, mechanism of action, or receptor interactions are especially encouraged.

The Journal of Medicinal Chemistry is committed to bridging laboratory innovation with clinical relevance. It supports a multidisciplinary approach, bringing together medicinal chemists, pharmacologists, biochemists, and computational scientists to accelerate the path from molecule to medicine.

The Journal of Medicinal Chemistry ensures a transparent and timely peer-review process through its Online Submission System, enabling authors to track their manuscript status with ease. All submissions undergo rigorous evaluation by qualified editorial board members or external reviewers, and final publication decisions are made based on consensus from at least two independent peer reviewers and the editor.

Authors are requested to submit manuscripts online at Submit Manuscript or Send as an e-mail attachment to the Editorial Office at editor@globalmeetx.net

Rapid Publication Service

Globalmeetx Publishing is offering wide range of opportunities, options and services for the prospective authors to publish their scholarly contributions.

The journal caters to the demands of the fast publication without compromising on the editorial quality including manuscript peer-review. This flexibility is being provided to ensure earliest author credibility to their respective contributions and this will also ensure timely dissemination of research outcomes for efficient integration, effective translation and reduced redundancy.

Authors have the option to choose between the standard open access publication service which takes its own course of time for complete publication process or can opt for rapid publication service wherein the article is published at the earliest date (Includes multiple subject experts commissioning for securing earliest peer-review comments). The authors can avail this flexibility based on the personal preference, funding agency guidelines or Institutional or organizational requirements.

Regardless of the option, all manuscripts undergo thorough peer-review process, editorial assessment and production process.

Fast Editorial Execution and Review Process (FEE-Review Process)

Authors who are willing to publish their articles under this mode can make a pre-payment of $99 towards express peer-review and editorial decision. First editorial decision in 3 days and final decision with review comments in 5 days from the date of submission. Galley proof generation will be done in next 2 days from acceptance or maximum 5 days (For manuscripts notified for revision by external reviewer).

Manuscripts accepted for publication will be charged regular APC.

Authors retain the copyright of their publication and the final version of the article will be published in both HTML and PDF formats as well as XML formats for transmitting to indexing databases. The editorial team of the Journal will ensure adherence to scientific publication guidelines.